The volatilome – investigation of volatile organic metabolites (VOM) as potential tumor markers in patients with head and neck squamous cell carcinoma (HNSCC)

Abstract Background Different organisms such as bacteria, molds and humans produce and release a relative unknown class of metabolites which are responsible for the individual olfactory pattern. These volatile organic metabolites (VOM) represent a kind of biosignature that reflects the sum of all mu...

Full description

Bibliographic Details
Main Authors: Philipp Opitz, Olf Herbarth
Format: Article
Language:English
Published: BMC 2018-07-01
Series:Journal of Otolaryngology - Head and Neck Surgery
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40463-018-0288-5
id doaj-9165afcf578543369b27ec88e76fffcd
record_format Article
spelling doaj-9165afcf578543369b27ec88e76fffcd2020-11-25T00:10:08ZengBMCJournal of Otolaryngology - Head and Neck Surgery1916-02162018-07-0147111310.1186/s40463-018-0288-5The volatilome – investigation of volatile organic metabolites (VOM) as potential tumor markers in patients with head and neck squamous cell carcinoma (HNSCC)Philipp Opitz0Olf Herbarth1Institute of Hygiene, Hospital Hygiene and Environmental Medicine, University Hospital LeipzigInstitute of Environmental Medicine and Hygiene, Faculty of Medicine, University of LeipzigAbstract Background Different organisms such as bacteria, molds and humans produce and release a relative unknown class of metabolites which are responsible for the individual olfactory pattern. These volatile organic metabolites (VOM) represent a kind of biosignature that reflects the sum of all multifactorial influences, including genetics, environmental factors, nutritional and disease status. As a result of pathological processes the individual body odor can be influenced by newly produced or altered compositions of the VOM. Until now, human VOM have been detected in various body media, such as on the skin, in the exhaled air as well as in body fluids such as saliva, mother’s milk, sweat, blood and urine. Methods In this retrospective case-control study urinary VOM of 53 therapy-naive patients with head and neck squamous cell carcinoma (HNSCC) and 82 healthy controls were semi-quantified by headspace solid-phase micro extraction (SPME) gas chromatography (GC) mass spectrometry (MS). At first, the procedure was optimized in respect to the extraction parameters. By using Student’s t-test significant differences in the VOM pattern with the corresponding p-values were obtained. For multivariate metabolite pattern recognition the hierarchical cluster analysis by Ward was applied, followed by the supervised partial least squares-discriminant analysis (PLS-DA). Results In total 81 VOMs could identified in the urine samples of all study participants, of which 25 were significantly increased and of which were 10 significantly reduced in HNSCC-patients compared to the controls. In addition, the multivariate statistics confirmed that on the basis of the renal excreted pattern of the volatile metabolites a high discrimination can be carried out between patients with a tumor in the head and neck region and controls. The substance group of the saturated, unbranched aldehydes makes a substantial contribution in this context. Conclusions The systematic pattern analysis of urinary VOMs appears to have potential clinical application as a diagnostic tool for cancer, especially HNSCC.http://link.springer.com/article/10.1186/s40463-018-0288-5Tumor markerUrinary metabolitesVolatile organic metabolites (VOM)Non-invasive diagnosticsHead and neck squamous cell carcinoma (HNSCC)Solid-phase micro extraction (SPME)
collection DOAJ
language English
format Article
sources DOAJ
author Philipp Opitz
Olf Herbarth
spellingShingle Philipp Opitz
Olf Herbarth
The volatilome – investigation of volatile organic metabolites (VOM) as potential tumor markers in patients with head and neck squamous cell carcinoma (HNSCC)
Journal of Otolaryngology - Head and Neck Surgery
Tumor marker
Urinary metabolites
Volatile organic metabolites (VOM)
Non-invasive diagnostics
Head and neck squamous cell carcinoma (HNSCC)
Solid-phase micro extraction (SPME)
author_facet Philipp Opitz
Olf Herbarth
author_sort Philipp Opitz
title The volatilome – investigation of volatile organic metabolites (VOM) as potential tumor markers in patients with head and neck squamous cell carcinoma (HNSCC)
title_short The volatilome – investigation of volatile organic metabolites (VOM) as potential tumor markers in patients with head and neck squamous cell carcinoma (HNSCC)
title_full The volatilome – investigation of volatile organic metabolites (VOM) as potential tumor markers in patients with head and neck squamous cell carcinoma (HNSCC)
title_fullStr The volatilome – investigation of volatile organic metabolites (VOM) as potential tumor markers in patients with head and neck squamous cell carcinoma (HNSCC)
title_full_unstemmed The volatilome – investigation of volatile organic metabolites (VOM) as potential tumor markers in patients with head and neck squamous cell carcinoma (HNSCC)
title_sort volatilome – investigation of volatile organic metabolites (vom) as potential tumor markers in patients with head and neck squamous cell carcinoma (hnscc)
publisher BMC
series Journal of Otolaryngology - Head and Neck Surgery
issn 1916-0216
publishDate 2018-07-01
description Abstract Background Different organisms such as bacteria, molds and humans produce and release a relative unknown class of metabolites which are responsible for the individual olfactory pattern. These volatile organic metabolites (VOM) represent a kind of biosignature that reflects the sum of all multifactorial influences, including genetics, environmental factors, nutritional and disease status. As a result of pathological processes the individual body odor can be influenced by newly produced or altered compositions of the VOM. Until now, human VOM have been detected in various body media, such as on the skin, in the exhaled air as well as in body fluids such as saliva, mother’s milk, sweat, blood and urine. Methods In this retrospective case-control study urinary VOM of 53 therapy-naive patients with head and neck squamous cell carcinoma (HNSCC) and 82 healthy controls were semi-quantified by headspace solid-phase micro extraction (SPME) gas chromatography (GC) mass spectrometry (MS). At first, the procedure was optimized in respect to the extraction parameters. By using Student’s t-test significant differences in the VOM pattern with the corresponding p-values were obtained. For multivariate metabolite pattern recognition the hierarchical cluster analysis by Ward was applied, followed by the supervised partial least squares-discriminant analysis (PLS-DA). Results In total 81 VOMs could identified in the urine samples of all study participants, of which 25 were significantly increased and of which were 10 significantly reduced in HNSCC-patients compared to the controls. In addition, the multivariate statistics confirmed that on the basis of the renal excreted pattern of the volatile metabolites a high discrimination can be carried out between patients with a tumor in the head and neck region and controls. The substance group of the saturated, unbranched aldehydes makes a substantial contribution in this context. Conclusions The systematic pattern analysis of urinary VOMs appears to have potential clinical application as a diagnostic tool for cancer, especially HNSCC.
topic Tumor marker
Urinary metabolites
Volatile organic metabolites (VOM)
Non-invasive diagnostics
Head and neck squamous cell carcinoma (HNSCC)
Solid-phase micro extraction (SPME)
url http://link.springer.com/article/10.1186/s40463-018-0288-5
work_keys_str_mv AT philippopitz thevolatilomeinvestigationofvolatileorganicmetabolitesvomaspotentialtumormarkersinpatientswithheadandnecksquamouscellcarcinomahnscc
AT olfherbarth thevolatilomeinvestigationofvolatileorganicmetabolitesvomaspotentialtumormarkersinpatientswithheadandnecksquamouscellcarcinomahnscc
AT philippopitz volatilomeinvestigationofvolatileorganicmetabolitesvomaspotentialtumormarkersinpatientswithheadandnecksquamouscellcarcinomahnscc
AT olfherbarth volatilomeinvestigationofvolatileorganicmetabolitesvomaspotentialtumormarkersinpatientswithheadandnecksquamouscellcarcinomahnscc
_version_ 1725409172048052224